Fatty liver

Diseases

Metabolic Dysfunction-Associated Fatty Liver Disease Shows Distinct Pathogenic Pathways

Research presented by scientists at Menoufia University has highlighted the complex relationship between cumulative metabolic burden and the severity of hepatic fibrosis and steatosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). The study revealed that metabolic burden strongly predicts steatosis but not fibrosis, indicating distinct pathogenic pathways. Fibrosis,

Diseases

Metabolic Dysfunction-Associated Fatty Liver Disease Shows Distinct Pathogenic Pathways

Research presented by scientists at Menoufia University has highlighted the complex relationship between cumulative metabolic burden and the severity of hepatic fibrosis and steatosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). The study revealed that metabolic burden strongly predicts steatosis but not fibrosis, indicating distinct pathogenic pathways. Fibrosis,

Diseases

Knowledge Gaps and Attitudes toward Fatty Liver Disease in Patients with Hepatitis B Combined with Metabolic-Associated Fatty Liver Disease

Patients with chronic hepatitis B virus (CHB) combined with metabolic-associated fatty liver disease (MAFLD) have poor knowledge and moderately positive attitudes towards fatty liver disease, a cross-sectional study conducted in the Chongqing region has found. The study, which involved 477 participants, aimed to assess the knowledge, attitudes, and practices (KAP)